Active ingredientFidarestatCat. No. P-F042-001CAS 136087-85-9Family · Pharmaceutical analytical standards
Fidarestat
An aldose reductase inhibitor patented in the mid-1980s and tested in the early 2000s in patients with diabetic neuropathy, a complication of diabetes that affects the nerves; it does not appear to have been approved. This family brings together the active ingredient and labelled standards.
Did you know?The enzyme it blocks turns glucose into sorbitol: when blood sugar is high this sugar alcohol builds up in nerves, the lens of the eye and the kidney glomeruli, because it crosses cell membranes poorly.
Go to the active ingredient →Active ingredientFidarestatCat. No. P-F042-001CAS 136087-85-9
Isotopically labelledFidarestat-d3Cat. No. P-F042-002No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.